Literature DB >> 2780462

Long-term symptomatic relief of postprandial hypoglycaemia following gastric surgery with a somatostatin analogue.

D P D'Cruz1, J Reynard, A J Tatman, P G Kopelman.   

Abstract

Somatostatin has been shown to be effective in the management of the dumping syndrome and there have been reports of the effective use of long acting somatostatin analogue in the management of this condition. However, there have been few reports of the prolonged use of a somatostatin analogue in the late dumping syndrome. We describe a patient in whom this management provided good long term symptomatic relief which was confirmed biochemically.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2780462      PMCID: PMC2429128          DOI: 10.1136/pgmj.65.760.116

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin.

Authors:  J Pless; W Bauer; U Briner; W Doepfner; P Marbach; R Maurer; T J Petcher; J C Reubi; J Vonderscher
Journal:  Scand J Gastroenterol Suppl       Date:  1986

2.  Pharmacokinetics of SMS 201-995 in healthy subjects.

Authors:  K Kutz; E Nüesch; J Rosenthaler
Journal:  Scand J Gastroenterol Suppl       Date:  1986

3.  Somatostatin and the dumping syndrome.

Authors:  R G Long; T E Adrian; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-23

4.  Therapy of acromegaly with SMS 201-995: long-term studies.

Authors:  G Tolis; S Malachtari; A Mortoglou; G Rigas; C Saridakis; T Kamillaris; J Andreou; Y Kimpouris; E del Pozo; A Yotis
Journal:  Scand J Gastroenterol Suppl       Date:  1986
  4 in total
  2 in total

Review 1.  Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.

Authors:  C B Lamers; A M Bijlstra; A G Harris
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

Review 2.  Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.

Authors:  Philippe E R Lheureux; Soheil Zahir; Andrea Penaloza; Mireille Gris
Journal:  Crit Care       Date:  2005-09-07       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.